Efficacy of newer generation antipsychotics in the treatment of schizophrenia
Authors:
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 28, 9-26
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- A Randomized Double-Blind Study of Risperidone and Olanzapine in the Treatment of Schizophrenia or Schizoaffective DisorderAmerican Journal of Psychiatry, 2001
- Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized TrialsAmerican Journal of Psychiatry, 2001
- The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophreniaInternational Journal of Psychiatry in Clinical Practice, 2000
- A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, ‘Seroquel’) and haloperidol in schizophreniaPsychological Medicine, 2000
- Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder A 6-Week Placebo-Controlled TrialNeuropsychopharmacology, 1999
- Therapeutic Equivalence of Risperidone Given Once Daily and Twice Daily in Patients With SchizophreniaJournal of Clinical Psychopharmacology, 1998
- Weight Gain With RisperidoneJournal of Clinical Psychopharmacology, 1997
- Antipsychotic and Anxiolytic Properties of Risperidone, Haloperidol, and Methotrimeprazine in Schizophrenic PatientsJournal of Clinical Psychopharmacology, 1996
- Positive and negative symptoms covary during clozapine treatment in schizophreniaJournal of Psychiatric Research, 1993
- Can meta-analyses be trusted?The Lancet, 1991